Cocain is ok but not lozenges 🤷‍♂️ LONDON, ON , March 14, 2023 /CNW/ - Indiva Limited (the " Company " or " Indiva ") (TSXV: NDVA), announced that it has received notification from Health Canada (the " Notice ") of its determination that certain of its lozenges have been improperly classified as an "extract" rather than an "edible" under applicable cannabis regulations. Heath Canada has requested that Indiva cease production of the lozenges. The lozenges subject to this determination are the Indiva Wild Cherry THC Lozenges and Life Lemon THC Lozenges in their 100 mg, 250 mg and 500 mg THC per package formats (the " Products "). Prior to the launch of the Products, the Company closely considered the regulatory requirements of the legislation, including with respect to product classification, and conducted substantial research. Consistent with the legislative requirements and the Company's research, the Company classified the Products as cannabis extracts. Currently, the Company has paused production of the Products as it consults with its advisors and considers next steps and a potential resolution of this matter. The Company may choose to continue manufacturing the Products in alternative packaging formats.
British Columbia Premier David Eby says he is "astonished" that Health Canada has granted a cannabis company the right to possess, produce, sell and distribute cocaine.
Adastra Labs in Langley, B.C., said in a news release that Health Canada gave it approval on Feb. 17 for an amendment under its controlled substance dealer’s licence.
Eby told a news conference on Thursday about funding for overdose prevention and mental health that, "if Health Canada did in fact do this," the federal agency did so without engaging the B.C. government or notifying the province.
The premier said the province will be contacting Health Canada for answers.